Dr Denis Dambois, head, research and innovation, Delegation of the European Union to India
In his exclusive interview with BioSpectrum's Raj Gunashekar, he shares the facts and insights about the EU markets, opportunities and programmes designed to assist international companies from countries like India in the area of Lifesciences. He also advises entrepreneurs who are keen to establish organizations in the EU circle.
Dr Dambois also speaks on the initial challenges companies will face and how EU can help organizations financially all the way from the beginning to the end.
Q: What opportunities does EU offer to Indian biotech, pharmaceutical and other lifesciences companies?
Dr Denis Dambois: Europe is especially interesting for lifesciences companies from emerging economies like India, seeking to leverage potential advantages in the largest economic market of the world.
With its technological leadership and manufacturing knowhow, Europe offers interesting opportunities for the acquisition or development of intellectual property (IP) as well as the development of sophisticated products.
For example, tax holidays are available in Switzerland for substantial investment projects. Also, France, UK and Ireland have similar provisions for startup companies.
Access to new technologies, products, skills and markets is critical for life science companies in order to maintain competiveness and generate growth in an environment characterized by price pressures, fast technological changes and increasingly sophisticated consumers.
The vocational training systems in many countries and top academic educational systems guarantee sizeable highly skilled workforces.